Viewing Study NCT03070002


Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2026-02-27 @ 8:48 AM
Study NCT ID: NCT03070002
Status: TERMINATED
Last Update Posted: 2018-11-20
First Post: 2017-02-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells
Sponsor: Northwestern University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Carcinoma Metastatic in the Bone View
None Circulating Tumor Cell Count View
None Estrogen Receptor Positive View
None HER2/Neu Negative View
None Progesterone Receptor Positive View
None Stage IV Breast Cancer View
Keywords: